Literature DB >> 7524763

Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor.

T Jippo1, H Ushio, S Hirota, H Mizuno, A Yamatodani, S Nomura, H Matsuda, Y Kitamura.   

Abstract

Decreased numbers of mast cells and abnormalities in the phenotype of mast cells are observed in the skin of mi/mi mutant mice. Recently, the mi locus was identified to encode a novel member of the basic-helix-loop-helix-leucine zipper protein family of transcription factors. Since nerve growth factor (NGF) has been reported to influence the proliferation and the phenotype of cultured mast cells (CMCs), we compared the effect of NGF between mi/mi and control normal (+/+) CMCs. Addition of NGF to the suboptimal dose of recombinant murine interleukin-3 (rmIL-3) increased the plating efficiency of +/+ CMCs, but not of mi/mi CMCs. Although +/+ CMCs were berberine sulfate-negative when cultured with rmIL-3 alone, +/+ CMCs became berberine sulfate-positive when cultured in the presence of both rmIL-3 and NGF, which suggests increased heparin content. In contrast, NGF did not influence the phenotype of mi/mi CMCs. +/+ CMCs significantly bound 125I-NGF, but mi/mi CMCs did not, which suggests a defect of NGF receptors in mi/mi CMCs. Both p75 and p140 molecules are known to be involved in the formation of NGF receptors. Although the expression of p140 messenger (m)RNA was comparable between +/+ and mi/mi CMCs, the expression of p75 mRNA was significantly lower in mi/mi CMCs than in +/+ CMCs. Taken together, the poor response of mi/mi CMCs to NGF appeared to be attributable to the impaired transcription of the p75 gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524763

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

Authors:  L M Coussens; W W Raymond; G Bergers; M Laig-Webster; O Behrendtsen; Z Werb; G H Caughey; D Hanahan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry.

Authors:  Y M Lee; T Jippo; D K Kim; Y Katsu; K Tsujino; E Morii; H M Kim; S Adachi; Y Nawa; Y Kitamura
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells.

Authors:  P Welker; J Grabbe; B Gibbs; T Zuberbier; B M Henz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

4.  Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization.

Authors:  T Jippo; K Tsujino; H M Kim; D K Kim; Y M Lee; Y Nawa; Y Kitamura
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  Tissue-dependent alteration of protease expression phenotype in murine peritoneal mast cells that were genetically labeled with green fluorescent protein.

Authors:  T Jippo; Y M Lee; Y Ge; D K Kim; M Okabe; Y Kitamura
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Expression of neurotrophins and their receptors in human bone marrow.

Authors:  E Labouyrie; P Dubus; A Groppi; F X Mahon; J Ferrer; M Parrens; J Reiffers; A de Mascarel; J P Merlio
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.

Authors:  K Hashimoto; T Tsujimura; Y Moriyama; A Yamatodani; M Kimura; K Tohya; M Morimoto; H Kitayama; Y Kanakura; Y Kitamura
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

8.  Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis.

Authors:  Ihsan Ekin Demir; Stephan Schorn; Elisabeth Schremmer-Danninger; Kun Wang; Timo Kehl; Nathalia A Giese; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.